2023年8月10日 · Fludrocortisone is used to treat conditions in which the body does not produce enough of its own steroids, such as Addison's disease, and salt-losing adrenogenital syndrome. Fludrocortisone may also be used for purposes not listed in this medication guide.

FLUDROCORTISONE (floo droe KOR ti sone) is a corticosteroid. It is used to treat Addison's disease and to treat a salt losing condition called adrenogenital syndrome.

2024年3月21日 · Fludrocortisone is a synthetic adrenal steroid with high mineralocorticoid activity and is practically devoid of glucocorticoid effect. As an analog, its mechanism of action and the permissive effects on α-adrenoreceptors are similar to the endogenous mineralocorticoid.

Find patient medical information for fludrocortisone oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

2025年2月1日 · Fludrocortisone is a corticosteroid (cortisone-like medicine). It belongs to the family of medicines called steroids. Your body naturally produces similar corticosteroids, which are necessary to maintain the balance of certain minerals and water for good health.

Fludrocortisone, sold under the brand name Florinef among others, is a corticosteroid used to treat congenital adrenal hyperplasia, postural hypotension, and adrenal insufficiency. [3][4][5] In adrenal insufficiency, it is generally taken together with hydrocortisone. [5] .

2017年9月30日 · Fludrocortisone is an oral medication used to treat Addison’s disease and salt-losing adrenogenital syndrome. Learn how it works, its warnings, and more.

Fludrocortisone is a mineralocorticoid used to treat adrenocortical insufficiency and salt-losing adrenogenital syndrome.

Fludrocortisone is a man-made oral corticosteroid. It is derived from hydrocortisone but is more potent than hydrocortisone. The effects of fludrocortisone including its effect on electrolyte balance and carbohydrate metabolism are stronger and prolonged in …

2022年7月5日 · Fludrocortisone acetate tablets are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome. Dosage depends on the severity of the disease and the response of the patient.